SIMULTANEOUS ASSESSMENT OF MIGRATION AND PROLIFERATION OF MURINE FIBREOSARCOMA CELLS, AS AFFECTED BY HYDROXYUREA, VINBLASTINE, CYTOCHALASIN-B, RAZOXANE AND INTERFERON
Ij. Haug et al., SIMULTANEOUS ASSESSMENT OF MIGRATION AND PROLIFERATION OF MURINE FIBREOSARCOMA CELLS, AS AFFECTED BY HYDROXYUREA, VINBLASTINE, CYTOCHALASIN-B, RAZOXANE AND INTERFERON, Cell proliferation, 26(3), 1993, pp. 251-261
Using porous cell culture chambers, we have simultaneously assessed gr
owth and locomotion of cancer cells to investigate whether certain age
nts affect cell motility in addition to cell division. First, cells fr
om a murine fibrosarcoma cell line, 1.0/L1, were grown in ordinary fla
sk cultures to determine appropriate cell inocula. Doses of agents wer
e selected to reduce the final 4 day culture cellularity to about 50%,
when present during the last two days of culturing. Secondly, the eff
ects of these agents on cell numbers in the porous chambers and on cel
l migration out of the chambers ('emigration fraction') were recorded.
We also examined, using a similar type of porous chamber, whether the
agents could affect leucocyte chemotaxis. Hydroxyurea (an inhibitor o
f DNA synthesis) reduced cancer cell emigration as well as cell growth
, without interfering with leucocyte chemotaxis. Cytochalasin B (a mic
rofilament disrupting agent) inhibited cancer cell motility and growth
, as well as leucocyte chemotaxis. Vinblastine (a microtubule disrupti
ng agent), at the very low dose chosen, reduced cancer cell growth, bu
t did not consistently affect the migration of either cell type. The e
xperimental anti-metastasis agent Razoxane reduced growth, but had no
detectable effects on motility. High doses of natural murine interfero
n-alpha/beta weakly inhibited both cancer cell growth and locomotion.
This motivates for further studies of these and other cytokines, as tr
eatment with agents inhibiting cancer cell locomotion might possibly p
revent peri-operative spread of cancer in patients.